Mesoblast (MESO) Net Income towards Common Stockholders: 2014-2023
Historic Net Income towards Common Stockholders for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to -$21.6 million.
- Mesoblast's Net Income towards Common Stockholders fell 2.34% to -$21.6 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$81.9 million, marking a year-over-year increase of 10.35%. This contributed to the annual value of -$102.1 million for FY2025, which is 16.13% down from last year.
- Latest data reveals that Mesoblast reported Net Income towards Common Stockholders of -$21.6 million as of Q2 2023, which was down 15.42% from -$18.7 million recorded in Q1 2023.
- In the past 5 years, Mesoblast's Net Income towards Common Stockholders registered a high of -$5.5 million during Q3 2019, and its lowest value of -$30.1 million during Q4 2019.
- Over the past 3 years, Mesoblast's median Net Income towards Common Stockholders value was -$21.5 million (recorded in 2022), while the average stood at -$22.0 million.
- Per our database at Business Quant, Mesoblast's Net Income towards Common Stockholders skyrocketed by 73.79% in 2019 and then plummeted by 374.18% in 2020.
- Quarterly analysis of 5 years shows Mesoblast's Net Income towards Common Stockholders stood at -$30.1 million in 2019, then increased by 14.80% to -$25.6 million in 2020, then dropped by 1.90% to -$26.1 million in 2021, then grew by 5.66% to -$24.6 million in 2022, then decreased by 2.34% to -$21.6 million in 2023.
- Its last three reported values are -$21.6 million in Q2 2023, -$18.7 million for Q1 2023, and -$24.6 million during Q4 2022.